These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 24446510)
1. Incidence of cerebral thromboembolic events during long-term follow-up in patients treated with transcatheter ablation for atrial fibrillation. Gaita F; Sardi D; Battaglia A; Gallo C; Toso E; Michielon A; Caponi D; Garberoglio L; Castagno D; Scaglione M Europace; 2014 Jul; 16(7):980-6. PubMed ID: 24446510 [TBL] [Abstract][Full Text] [Related]
2. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706 [TBL] [Abstract][Full Text] [Related]
3. Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis. Toso E; Peyracchia M; Matta M; D'Ascenzo F; Gaita F; Kornej J; Hindricks G; Jared Bunch T; Saliba W Int J Cardiol; 2018 Nov; 270():172-179. PubMed ID: 29945808 [TBL] [Abstract][Full Text] [Related]
4. Anticoagulation use and clinical outcomes after catheter ablation in patients with persistent and longstanding persistent atrial fibrillation. Liang JJ; Elafros MA; Mullen MT; Muser D; Hayashi T; Enriquez A; Pathak RK; Zado ES; Santangeli P; Arkles JS; Schaller RD; Supple GE; Frankel DS; Garcia FC; Deo R; Lin D; Riley MP; Nazarian S; Dixit S; Marchlinski FE; Callans DJ J Cardiovasc Electrophysiol; 2018 Jun; 29(6):823-832. PubMed ID: 29513397 [TBL] [Abstract][Full Text] [Related]
5. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study. Saad EB; d'Avila A; Costa IP; Aryana A; Slater C; Costa RE; Inácio LA; Maldonado P; Neto DM; Camiletti A; Camanho LE; Polanczyk CA Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):615-21. PubMed ID: 21841192 [TBL] [Abstract][Full Text] [Related]
6. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation. Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452 [TBL] [Abstract][Full Text] [Related]
7. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744 [TBL] [Abstract][Full Text] [Related]
8. Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry. Kornej J; Kosiuk J; Hindricks G; Arya A; Sommer P; Rolf S; Husser D; Lip GY; Bollmann A Clin Res Cardiol; 2015 Jul; 104(7):603-10. PubMed ID: 25707763 [TBL] [Abstract][Full Text] [Related]
9. Comparison of HAS-BLED and HAS-BED Versus CHADS Poli D; Antonucci E; Pengo V; Testa S; Palareti G Am J Cardiol; 2017 Apr; 119(7):1012-1016. PubMed ID: 28237286 [TBL] [Abstract][Full Text] [Related]
10. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial. Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272 [TBL] [Abstract][Full Text] [Related]
11. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Huo Y; Piorkowski C; Bollmann A Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):281-7. PubMed ID: 24610790 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial. Apostolakis S; Lane DA; Buller H; Lip GY Thromb Haemost; 2013 Nov; 110(5):1074-9. PubMed ID: 24048467 [TBL] [Abstract][Full Text] [Related]
13. The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran. Ichiki H; Oketani N; Ishida S; Iriki Y; Okui H; Maenosono R; Namino F; Ninomiya Y; Miyata M; Hamasaki S; Tei C Pacing Clin Electrophysiol; 2013 Nov; 36(11):1328-35. PubMed ID: 23952291 [TBL] [Abstract][Full Text] [Related]
14. [Association between CHADS2 score and long-term atrial fibrillation recurrence rate after catheter ablation]. Hu X; Wang Q; Sun J; Feng X; Zhang P; Liu B; Wang J; Zhang R; Li Y Zhonghua Xin Xue Guan Bing Za Zhi; 2014 May; 42(5):379-83. PubMed ID: 25042914 [TBL] [Abstract][Full Text] [Related]
15. Risk of stroke or transient ischemic attack after atrial fibrillation ablation with oral anticoagulant use guided by ECG monitoring and pulse assessment. Riley MP; Zado E; Hutchinson MD; Lin D; Bala R; Garcia FC; Callans DJ; Cooper JM; Verdino RJ; Dixit S; Marchlinski FE J Cardiovasc Electrophysiol; 2014 Jun; 25(6):591-6. PubMed ID: 24533561 [TBL] [Abstract][Full Text] [Related]
16. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219 [TBL] [Abstract][Full Text] [Related]
17. Rationale and design of the ODIn-AF Trial: randomized evaluation of the prevention of silent cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation. Schrickel JW; Linhart M; Bänsch D; Thomas D; Nickenig G Clin Res Cardiol; 2016 Feb; 105(2):95-105. PubMed ID: 26514352 [TBL] [Abstract][Full Text] [Related]
18. [Cardioembolic stroke in atrial fibrillation and new anticoagulation criteria: a therapeutic dare]. Perez-Ortega I; Moniche-Alvarez F; Jimenez-Hernandez MD; Gonzalez-Marcos JR Rev Neurol; 2012 Jul; 55(2):74-80. PubMed ID: 22760766 [TBL] [Abstract][Full Text] [Related]
19. Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation. Eitel C; Koch J; Sommer P; John S; Kircher S; Bollmann A; Arya A; Piorkowski C; Hindricks G Europace; 2013 Nov; 15(11):1587-93. PubMed ID: 23703362 [TBL] [Abstract][Full Text] [Related]
20. Anticoagulation after catheter ablation of atrial fibrillation: An unnecessary evil? A systematic review and meta-analysis. Proietti R; AlTurki A; Di Biase L; China P; Forleo G; Corrado A; Marras E; Natale A; Themistoclakis S J Cardiovasc Electrophysiol; 2019 Apr; 30(4):468-478. PubMed ID: 30575175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]